SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-156446
Filing Date
2021-05-10
Accepted
2021-05-10 17:23:26
Documents
70
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d160607d10q.htm   iXBRL 10-Q 1003125
2 EX-31.1 d160607dex311.htm EX-31.1 10254
3 EX-31.2 d160607dex312.htm EX-31.2 10239
4 EX-32.1 d160607dex321.htm EX-32.1 4304
5 EX-32.2 d160607dex322.htm EX-32.2 4289
  Complete submission text file 0001193125-21-156446.txt   5005130

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20210331.xsd EX-101.SCH 43409
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20210331_cal.xml EX-101.CAL 43398
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20210331_def.xml EX-101.DEF 169259
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20210331_lab.xml EX-101.LAB 339176
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20210331_pre.xml EX-101.PRE 273897
11 EXTRACTED XBRL INSTANCE DOCUMENT d160607d10q_htm.xml XML 793312
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 21908564
SIC: 2834 Pharmaceutical Preparations